Emerging therapeutic targets in bipolar mood disorder. - Wikidata - awgldk - TriplyDB

Emerging therapeutic targets in bipolar mood disorder.

Emerging therapeutic targets in bipolar mood disorder.

http://www.wikidata.org/entity/Q35050429

about

A systematic review of existing data on long-term lithium therapy: neuroprotective or neurotoxic?Inhibition of phosphoglucomutase activity by lithium alters cellular calcium homeostasis and signaling in Saccharomyces cerevisiae.

P2860

Q33284843-0CE9E2C1-DD92-47FA-91C5-EEBC6F82D67F Q45259237-0A996550-C8C5-4A26-B066-F88ED5304B8D

P2860

Emerging therapeutic targets in bipolar mood disorder.

http://www.wikidata.org/entity/Q35050429

description

2001 nî lūn-bûn

@nan

2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Emerging therapeutic targets in bipolar mood disorder.

@ast

Emerging therapeutic targets in bipolar mood disorder.

@en

type

label

Emerging therapeutic targets in bipolar mood disorder.

@ast

Emerging therapeutic targets in bipolar mood disorder.

@en

prefLabel

Emerging therapeutic targets in bipolar mood disorder.

@ast

Emerging therapeutic targets in bipolar mood disorder.

@en

P1433

Q35050429-92F369D0-9DFC-4663-B7AA-600E9F2C425C

P1476

Q35050429-6175EFC2-0B0C-43D3-9150-E32A6000C0C4

P2093

Q35050429-0CBAC29F-8387-41A0-A23B-5FF73EA97F67

Q35050429-71744A0F-4AA6-431C-9045-E7C3FA3D5F73

P2860

Q35050429-07E9F4D9-D3D0-478D-962C-19C90B7CBB55

Q35050429-099D0EE3-9D5A-4D4D-AA94-827B55AEEDE5

Q35050429-0AE0166C-40A1-4D79-B1D7-10566946B12D

Q35050429-0C998456-4A92-46D9-B060-86858BDC0173

Q35050429-143100C7-5298-4500-9933-1C8EA2E46623

Q35050429-1541FB71-45E8-48F0-B778-1723B140849A

Q35050429-1562E186-4BC9-4E6D-8564-AC13C3ABE0B0

Q35050429-1813752A-8310-48EC-909F-CFF72E400472

Q35050429-1E6D0015-0F11-4863-BA6E-6C7C58D5663D

Q35050429-238243D2-5D67-4E30-B411-7A30FAD5D2D3

P304

Q35050429-ED46FA9D-923F-42E4-83B1-545044F1B8C0

P31

Q35050429-9C89A7DA-73BB-4717-B0F9-EFA9F450E9B1

P356

Q35050429-3C345193-44E0-4D30-B106-A19459DFD0C3

P407

Q35050429-FF06FA6D-F5AB-4FF8-AB12-5D9A61D998BF

P433

Q35050429-6C2F6C2C-660F-4489-BA8B-B4E170AADFF4

P478

Q35050429-E49B3CAD-7B5E-48FD-9E14-01E0920DC47B

P577

Q35050429-E8258DFB-D4CC-483F-8AC5-F91A53176B6A

P698

Q35050429-73AC8142-457F-4183-986F-B3579339B9C5

P356

14728222.5.5.587

P1433

Expert Opinion on Therapeutic Targets

P1476

Emerging therapeutic targets in bipolar mood disorder.

@en

P2093

Jair C Soares

http://www.w3.org/2001/XMLSchema#string

Roberto B Sassi

http://www.w3.org/2001/XMLSchema#string

P2860

A molecular mechanism for the effect of lithium on development

Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors

Chronic lithium and sodium valproate both decrease the concentration of myo-inositol and increase the concentration of inositol monophosphates in rat brain

Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial

Controlled trials of inositol in psychiatry

Neural and developmental actions of lithium: a unifying hypothesis

The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS

Protein kinase inhibition by omega-3 fatty acids.

Life-or-death decisions by the Bcl-2 protein family.

Decreased anterior cingulate myo-inositol/creatine spectroscopy resonance with lithium treatment in children with bipolar disorder.

P304

587-599

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14728222.5.5.587

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2001-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12540285

http://www.w3.org/2001/XMLSchema#string